Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality Read more about Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality
Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Read more about Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Accuray Reports Fiscal 2022 Second Quarter Financial Results Read more about Accuray Reports Fiscal 2022 Second Quarter Financial Results
Accuray to Report Second Quarter Fiscal 2022 Financial Results on January 26, 2022 Read more about Accuray to Report Second Quarter Fiscal 2022 Financial Results on January 26, 2022
Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve Read more about Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve
Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery Read more about Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery
Accuray To Participate at Stifel 2021 Virtual Healthcare Conference Read more about Accuray To Participate at Stifel 2021 Virtual Healthcare Conference
Accuray Reports Fiscal 2022 First Quarter Financial Results Read more about Accuray Reports Fiscal 2022 First Quarter Financial Results
Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients Read more about Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer Patients
Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range between $420 million to $427 million Read more about Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range between $420 million to $427 million
